The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Notable Guests
Episodes (421)
Author Interview: Kim Lauper
The IMID Forum
Discussing AxSpA: Episode 2
The IMID Forum
Discussing Rheumatology: July 2022
The IMID Forum
Discussing PsA: Episode 2
The IMID Forum
Author Interview: Diego Kyburz
The IMID Forum
Discussing Rheumatology: June 2022
The IMID Forum
Discussing axSpA: Episode 1
The IMID Forum
Discussing PsA: Episode 1
The IMID Forum
DAY 4: EULAR 2022 Daily Highlights
The IMID Forum
DAY 3: EULAR 2022 Daily Highlights
The IMID Forum
DAY 2: EULAR 2022 Daily Highlights
The IMID Forum
DAY 1, axSpA: EULAR 2022 Daily Highlights
The IMID Forum
DAY 1, RA: EULAR 2022 Daily Highlights
The IMID Forum
DAY 1, PsA: EULAR 2022 Daily Highlights
The IMID Forum
EULAR 2022 Preview Podcast
The IMID Forum
Discussing Rheumatology: May 2022
The IMID Forum
Author Interview: Professor Peter Taylor
The IMID Forum
Discussing Rheumatology: Pain, pneumonia and perspectives
The IMID Forum
Author Interview: Professor Rüdiger Müller
The IMID Forum
Discussing Rheumatology: March 2022
The IMID Forum
Author Interview: Professor Roy Fleischmann
The IMID Forum
Discussing Rheumatology: Tofacitinib safety and dose-switching in RA
The IMID Forum
ACR1540 Ana Rita Cruz - Machado
The IMID Forum
ACR1087 Omar Alsaed
The IMID Forum
ORAL Surveillance Author Interview – Roy Fleischmann
The IMID Forum
Author Author Interview: Professor Kevin Winthrop
The IMID Forum
Discussing Rheumatology: HZ and ILD with tofacitinib in RA
The IMID Forum
Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA
The IMID Forum
Author Interview: Professor Kevin Winthrop (December 2021)
The IMID Forum
Author Interview: Professor Kevin Winthrop (November 2021)
The IMID Forum
Insights at ACR 2021: Basic Science / Beyond RA
The IMID Forum
Insights at ACR 2021: PROs and JAK Treatment
The IMID Forum
Insights at ACR 2021: Clinical Outcomes in RA
The IMID Forum
Insights at ACR 2021: JAKs in Spondyloarthritis
The IMID Forum
Insights at ACR 2021: COVID-19 Vaccination and Rituximab
The IMID Forum
Insights at ACR 2021: Impact of COVID-19 on Practice
The IMID Forum
Insights at ACR 2021: COVID Vaccinations
The IMID Forum
Author Interview: Professor Atul Deodhar
The IMID Forum
Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA
The IMID Forum
Author Interview: Professor Roy Fleischmann
The IMID Forum
ACR 2021: Day 4 Highlights
The IMID Forum
ACR 2021: Day 3 Highlights
The IMID Forum
ACR 2021: Day 2 Highlights
The IMID Forum
Discussing Rheumatology: Herpes Zoster and HBV
The IMID Forum
ACR 2021: Day 1 Highlights
The IMID Forum
ACR 2021 Preview Podcast
The IMID Forum
Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness
The IMID Forum
Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination T...
The IMID Forum
Rheumatology Author Professor Kurt de Vlam: Pain Improvements
The IMID Forum
Rheumatology Author Professor Strand: Upadacitinib and PROs
The IMID Forum